Description
About AOD-9604
AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone (hGH). It represents a small, defined section of the much larger growth hormone molecule rather than the complete hormone.
Researchers developed and studied this fragment to investigate whether some of the metabolic activity associated with growth hormone could be examined separately from its broader growth-related effects.
This makes AOD-9604 particularly relevant to research examining fat metabolism, fat oxidation, energy expenditure and how a specific peptide sequence can influence metabolic signalling.
Published animal research has reported changes in body fat, fat oxidation and energy-related metabolism under specific experimental conditions.
These findings allow researchers to investigate whether a defined region of growth hormone contributes to metabolic processes independently from the wider biological activity of the complete hormone.
Pronoia supplies AOD-9604 in a 5mg lyophilised research format with batch traceability and supporting documentation available for the supplied material.
Product Specification
Product: AOD-9604
Strength: 5mg
Material class: Synthetic peptide fragment
Parent molecule: Human growth hormone (hGH)
Region: C-terminal growth-hormone-derived fragment
Research focus: Fat metabolism and fat oxidation
Form: Lyophilised solid
Pronoia minimum purity standard: ≥99%
Batch traceability: Maintained
SKU: PB-AOD-5
Testing & Batch Documentation
Pronoia maintains a structured quality, testing and traceability process for AOD-9604, with supporting documentation retained for the supplied research material.
- Independent third-party analytical testing
- Pronoia minimum accepted purity standard of ≥99%
- Full batch traceability
- Batch-separated and labelled inventory
- Physical inventory routinely reconciled with digital stock records
- Temperature-controlled cold storage
- Certificate of Analysis (COA) and Safety Data Sheet (SDS) documentation available
The Certificate of Analysis should be treated as the authoritative reference for the analytical results reported for an individual batch.
Research Context
Published research has examined AOD-9604 in laboratory and animal models investigating how a specific fragment of human growth hormone influences fat metabolism.
In obese mouse models, researchers reported findings including:
- Reduced body weight and body fat under the tested conditions
- Increased fat oxidation and energy expenditure
- Increased sensitivity of fat tissue to processes involved in fat breakdown
- Changes in beta-adrenergic signalling, a pathway involved in regulating fat metabolism
Together, these findings make AOD-9604 relevant to research investigating whether metabolic activity associated with a specific growth-hormone fragment can be separated from the wider effects of the complete hormone.
AOD-9604 has also progressed into human clinical research. A published analysis combining data from six randomised, double-blind, placebo-controlled trials primarily examined safety and tolerability. That research reported no increase in serum IGF-1 and no negative effect on carbohydrate metabolism under the conditions studied.
The published human research primarily addresses safety and tolerability and should not be interpreted as demonstrating in humans the metabolic effects reported in animal experiments.
These findings describe results from specific experimental and clinical research settings and do not establish suitability for human or veterinary use.
Storage & Handling
AOD-9604 is supplied in lyophilised form and should be stored according to the conditions specified by Pronoia and the applicable batch documentation.
Pronoia stock is maintained in temperature-controlled cold storage and organised by identifiable batch prior to dispatch.
The material should be protected from unnecessary exposure to heat, moisture and light and handled using appropriate laboratory procedures.
Where batch-specific storage or handling information is supplied, that information should take precedence.
UK Delivery
AOD-9604 is dispatched from Pronoia’s UK stock using tracked delivery.
Current availability and dispatch information are shown directly on the product page, with tracking supplied following dispatch.
Orders are prepared through Pronoia’s established research-product fulfilment process, with applicable delivery conditions remaining subject to Pronoia’s current delivery terms.
Research Use
AOD-9604 supplied by Pronoia Bio is intended for laboratory research and experimental use only.
It is not supplied for human or veterinary use and should not be treated as a medicine, food product or consumer supplement.
Pronoia does not provide dosage, treatment or administration guidance for this research material.
